E

Epitomee Medical Ltd
TASE:EPIT

Watchlist Manager
Epitomee Medical Ltd
TASE:EPIT
Watchlist
Price: 887.3 ILS 0.16% Market Closed
Market Cap: 261.9m ILS
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

EPIT Price Targets Summary
Epitomee Medical Ltd

There are no price targets for EPIT.
EPIT Lowest Forecast
Wall Street Target
Not Available
EPIT Average Forecast
Wall Street Target
Not Available
EPIT Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Epitomee Medical Ltd Competitors:
Price Targets
688236
Beijing Chunlizhengda Medical Instruments Co Ltd
6% Upside
NNOX
Nano-X Imaging Ltd
128% Upside
7817
Paramount Bed Holdings Co Ltd
7% Upside
MEDX
Medmix Ltd
93% Upside
688236
Beijing Chunlizhengda Medical Instruments Co Ltd
6% Upside
NNOX
Nano-X Imaging Ltd
128% Upside
7817
Paramount Bed Holdings Co Ltd
7% Upside
MEDX
Medmix Ltd
93% Upside
BDX
Becton Dickinson and Co
29% Upside
MEDI
Medistim ASA
15% Downside
O
OPTOMED
Optomed Oyj
25% Upside
DEMANT
Demant A/S
12% Upside

Revenue
Forecast

Revenue Estimate
Epitomee Medical Ltd

Revenue forecast
is not available for
Epitomee Medical Ltd

Operating Income
Forecast

Operating Income Estimate
Epitomee Medical Ltd

Operating Income forecast
is not available for
Epitomee Medical Ltd

Net Income
Forecast

Net Income Estimate
Epitomee Medical Ltd

Net Income forecast
is not available for
Epitomee Medical Ltd

See Also

Summary
EPIT intrinsic value, competitors valuation, and company profile.
DCF Valuation
EPIT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EPIT stock valuation using valuation multiples.
Wall Street Estimates
EPIT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EPIT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EPIT's stock price target?
Not Available

EPIT doesn't have any price targets made by Wall Street professionals.

Back to Top
ALPHA SPREAD
Follow us
Join more than 258,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.